Given that CKD and its risk factor diseases are expected to increase in the next few years and taking into account that albumin tests are currently highly requested and used in very different patient populations, it is necessary to find a screening method which should be cheap, fast and with adequate sensitivity to deal with this increasing workload and to reduce cost and time effort. Here, ALB is linked to chronic kidney disease.